PSP94: Evaluation of prognostic utility in patients treated with radiotherapy for nonmetastatic prostate cancer

Prostate Journal

Volumn 2, Issue 2, 2000, Pages 94-101

  Bauman, G S ^a   Xuan, J ^b   Chin, J ^b   Sakai, H ^c   Guo, Y ^d   Garde, S ^d   Fraser, J ^d   Venkatesan, V M ^a  

^a London Regional Cancer Centre   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c NAGASAKI UNIVERSITY   (Japan)

^d Procyon Biopharma Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; BETA MICROSEMINOPROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SERUM; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 0034127312     PISSN: 10955100     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1411.2000.22007.x     Document Type: Article

References (17)